US 9980904
Dry powder formulation
granted A61KA61K31/00A61K31/137
Quick answer
US patent 9980904 (Dry powder formulation) held by Teva Branded Pharmaceutical Products R&D, Inc. expires Mon May 24 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Teva Branded Pharmaceutical Products R&D, Inc.
- Grant date
- Tue May 29 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 24 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/00, A61K31/137, A61K31/167, A61K31/56